ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer

NCT03485729 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
27
Enrollment
INDUSTRY
Sponsor class

Stopped This study was terminated due to a change in the Sponsor's corporate priorities. The decision to terminate the study was not based on any safety concerns.

Conditions

Interventions

Sponsor

Jazz Pharmaceuticals

Collaborators